IM Cannabis (NASDAQ:IMCC) and Senestech (NASDAQ:SNES) Head to Head Analysis

Senestech (NASDAQ:SNES) and IM Cannabis (NASDAQ:IMCC) are both small-cap medical companies, but which is the superior business? We will contrast the two companies based on the strength of their valuation, analyst recommendations, profitability, risk, earnings, dividends and institutional ownership.

Earnings & Valuation

This table compares Senestech and IM Cannabis”s top-line revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Senestech	$2.23 million	4.08	-$6.38 million	($1.89)	-0.91
IM Cannabis	$39.17 million	0.04	-$8.10 million	($1.75)	-0.13

Senestech has higher earnings, but lower revenue than IM Cannabis. Senestech is trading at a lower price-to-earnings ratio than IM Cannabis, indicating that it is currently the more affordable of the two stocks.

Institutional and Insider Ownership

5.2% of Senestech shares are held by institutional investors. Comparatively, 7.7% of IM Cannabis shares are held by institutional investors. 2.2% of Senestech shares are held by company insiders. Comparatively, 5.9% of IM Cannabis shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

Analyst Ratings

This is a breakdown of current recommendations for Senestech and IM Cannabis, as reported by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Senestech	1	1	0	1	2.33
IM Cannabis	1	0	0	0	1.00

Volatility and Risk

Senestech has a beta of 0.28, indicating that its stock price is 72% less volatile than the S&P 500. Comparatively, IM Cannabis has a beta of 1.99, indicating that its stock price is 99% more volatile than the S&P 500.

Profitability

This table compares Senestech and IM Cannabis’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Senestech	-304.22%	-67.60%	-49.21%
IM Cannabis	-27.65%	-585.96%	-39.96%

Summary

IM Cannabis beats Senestech on 8 of the 13 factors compared between the two stocks.

About Senestech

SenesTech, Inc. develops a technology for managing animal pest populations through fertility control. It offers ContraPest, a liquid bait that limits reproduction of male and female rats. The company was incorporated in 2004 and is headquartered in Phoenix, Arizona.

About IM Cannabis

IM Cannabis Corp. engages in breeding, growing, and supply of medical cannabis products in Israel and Germany. It offers cannabis flowers and strain-specific cannabis extracts under the IMC brand; and dried flower, pre-rolls, minis, and full spectrum extracts offerings under the WAGNERS and BLKMKT brands. The company serves medical patients. IM Cannabis Corp. is headquartered in Tel Aviv, Israel.